Emissary International LLC   Report issue

For profit Phase 2 Phase 3
Founded: Austin TX United States (1995)

Organization Overview

First Clinical Trial
2005
NCT00224770
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

alteplase (Activase) (3 trials)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (1)

glucagon (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Hemorrhage (Phase 3)

Hemorrhage (Phase 3)

Hypoglycemia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 3